Data di Pubblicazione:
2013
Citazione:
Type I Interferons : Ancient Peptides with Still Under-Discovered Anti-Cancer Properties / M. Caraglia, A. Dicitore, M. Marra, S. Castiglioni, L. Persani, P. Sperlongano, P. Tagliaferri, A. Abbruzzese, G. Vitale. - In: PROTEIN AND PEPTIDE LETTERS. - ISSN 0929-8665. - 20:4(2013 Apr 01), pp. 412-423.
Abstract:
Type I interferons (IFNs) represent a group of cytokines that act through a common receptor composed by two chains (IFNAR-1 and IFNAR-2). Several in vitro and in vivo studies showed a potent antitumor activity induced by these cytokines. IFN-α, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator of cancer cell growth and differentiation, affecting cellular communication and signal transduction pathways. IFN-α, is currently the most used cytokine in the treatment of cancer. However, the potential anti-tumour activity of IFN-α is limited by the activation of tumour resistance mechanisms. This article reviews the current knowledge about the antitumor activity of type I IFNs, focusing on new potential strategies able to strengthen the antitumor activity of these cytokines.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Egf-p; Farnesyltransferase inhibitors; Interferon-alpha; Interferon-beta; Mtor; Pegylated interferons; Stats; Type i interferons
Elenco autori:
M. Caraglia, A. Dicitore, M. Marra, S. Castiglioni, L. Persani, P. Sperlongano, P. Tagliaferri, A. Abbruzzese, G. Vitale
Link alla scheda completa: